Top Markets
Coin of the day
Enveric Biosciences, Inc. Enveric Biosciences, Inc.

Enveric Biosciences, Inc.

ENVB
Rang in Aktien #38583
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse... Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Aktienkurs
$1.52
Marktkapitalisierung
$906.74K
Veränderung (1 Tag)
0.58%
Veränderung (1 Jahr)
-88.60%
Land
US
Handel Enveric Biosciences, Inc. (ENVB)

Kategorie

Dividendenrendite-Verlauf für Enveric Biosciences, Inc. (ENVB)
Dividendenrendite (TTM) von Enveric Biosciences, Inc. (Aktienkürzel: ENVB) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Enveric Biosciences, Inc. (ENVB) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber